Anti-senile dementia medicine and preparation method thereof
The invention belongs to the technical field of medicines, and particularly relates to an anti-senile dementia medicine and a preparation method thereof. When the total mass of the anti-senile dementia medicine is 100%, and the anti-senile dementia medicine comprises the following components: 30%-60...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ZENG WUJIANG LIN DEQIU CHEN SHUICHUN CHEN HUASHENG LIN ZHOU LIN XIAOYA |
| description | The invention belongs to the technical field of medicines, and particularly relates to an anti-senile dementia medicine and a preparation method thereof. When the total mass of the anti-senile dementia medicine is 100%, and the anti-senile dementia medicine comprises the following components: 30%-60% of fucose; 10%-40% of astragalus polysaccharide; 10%-40% of lentinan; and 20%-50% of snake venom nerve growth factors. The anti-senile dementia medicine provided by the invention has a better treatment effect on senile dementia through the synergistic effect of all the components, and can promote the release of acetylcholine in limbs and trunks, cause the balance of acetylcholine and dopamine in the brain, treat and relieve the symptoms of senile dementia and recover intelligence and memory to a certain extent.
本申请属于医药技术领域，尤其涉及一种抗老年痴呆药物及其制备方法。其中，以所述抗老年痴呆药物的总质量为100％计，包括以下组分：岩藻糖30％～60％；黄芪多糖10％～40％；香菇多糖10％～40％；蛇毒神经生长因子20％～50％。本申请提供的抗老年痴呆药物，通过各组分的协同配合作用，对老年性痴呆有较好的治疗作用，能促进四肢躯干的乙酰胆碱释放，导致脑内的乙酰胆碱及多巴胺平衡，治疗和缓解老年性痴呆的症状，以及在一 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN113413461A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN113413461A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN113413461A3</originalsourceid><addsrcrecordid>eNrjZLBxzCvJ1C1OzcvMSVVISc1NBXITFXJTUzKTM_NSFRLzUhQKilILEosSSzLz84ASJRn5KQolGalFqflpPAysaYk5xam8UJqbQdHNNcTZQze1ID8-tbggMTk1L7Uk3tnP0NDYBIjMDB2NiVEDAOzXL9c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Anti-senile dementia medicine and preparation method thereof</title><source>esp@cenet</source><creator>ZENG WUJIANG ; LIN DEQIU ; CHEN SHUICHUN ; CHEN HUASHENG ; LIN ZHOU ; LIN XIAOYA</creator><creatorcontrib>ZENG WUJIANG ; LIN DEQIU ; CHEN SHUICHUN ; CHEN HUASHENG ; LIN ZHOU ; LIN XIAOYA</creatorcontrib><description>The invention belongs to the technical field of medicines, and particularly relates to an anti-senile dementia medicine and a preparation method thereof. When the total mass of the anti-senile dementia medicine is 100%, and the anti-senile dementia medicine comprises the following components: 30%-60% of fucose; 10%-40% of astragalus polysaccharide; 10%-40% of lentinan; and 20%-50% of snake venom nerve growth factors. The anti-senile dementia medicine provided by the invention has a better treatment effect on senile dementia through the synergistic effect of all the components, and can promote the release of acetylcholine in limbs and trunks, cause the balance of acetylcholine and dopamine in the brain, treat and relieve the symptoms of senile dementia and recover intelligence and memory to a certain extent.
本申请属于医药技术领域，尤其涉及一种抗老年痴呆药物及其制备方法。其中，以所述抗老年痴呆药物的总质量为100％计，包括以下组分：岩藻糖30％～60％；黄芪多糖10％～40％；香菇多糖10％～40％；蛇毒神经生长因子20％～50％。本申请提供的抗老年痴呆药物，通过各组分的协同配合作用，对老年性痴呆有较好的治疗作用，能促进四肢躯干的乙酰胆碱释放，导致脑内的乙酰胆碱及多巴胺平衡，治疗和缓解老年性痴呆的症状，以及在一</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210921&DB=EPODOC&CC=CN&NR=113413461A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210921&DB=EPODOC&CC=CN&NR=113413461A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZENG WUJIANG</creatorcontrib><creatorcontrib>LIN DEQIU</creatorcontrib><creatorcontrib>CHEN SHUICHUN</creatorcontrib><creatorcontrib>CHEN HUASHENG</creatorcontrib><creatorcontrib>LIN ZHOU</creatorcontrib><creatorcontrib>LIN XIAOYA</creatorcontrib><title>Anti-senile dementia medicine and preparation method thereof</title><description>The invention belongs to the technical field of medicines, and particularly relates to an anti-senile dementia medicine and a preparation method thereof. When the total mass of the anti-senile dementia medicine is 100%, and the anti-senile dementia medicine comprises the following components: 30%-60% of fucose; 10%-40% of astragalus polysaccharide; 10%-40% of lentinan; and 20%-50% of snake venom nerve growth factors. The anti-senile dementia medicine provided by the invention has a better treatment effect on senile dementia through the synergistic effect of all the components, and can promote the release of acetylcholine in limbs and trunks, cause the balance of acetylcholine and dopamine in the brain, treat and relieve the symptoms of senile dementia and recover intelligence and memory to a certain extent.
本申请属于医药技术领域，尤其涉及一种抗老年痴呆药物及其制备方法。其中，以所述抗老年痴呆药物的总质量为100％计，包括以下组分：岩藻糖30％～60％；黄芪多糖10％～40％；香菇多糖10％～40％；蛇毒神经生长因子20％～50％。本申请提供的抗老年痴呆药物，通过各组分的协同配合作用，对老年性痴呆有较好的治疗作用，能促进四肢躯干的乙酰胆碱释放，导致脑内的乙酰胆碱及多巴胺平衡，治疗和缓解老年性痴呆的症状，以及在一</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBxzCvJ1C1OzcvMSVVISc1NBXITFXJTUzKTM_NSFRLzUhQKilILEosSSzLz84ASJRn5KQolGalFqflpPAysaYk5xam8UJqbQdHNNcTZQze1ID8-tbggMTk1L7Uk3tnP0NDYBIjMDB2NiVEDAOzXL9c</recordid><startdate>20210921</startdate><enddate>20210921</enddate><creator>ZENG WUJIANG</creator><creator>LIN DEQIU</creator><creator>CHEN SHUICHUN</creator><creator>CHEN HUASHENG</creator><creator>LIN ZHOU</creator><creator>LIN XIAOYA</creator><scope>EVB</scope></search><sort><creationdate>20210921</creationdate><title>Anti-senile dementia medicine and preparation method thereof</title><author>ZENG WUJIANG ; LIN DEQIU ; CHEN SHUICHUN ; CHEN HUASHENG ; LIN ZHOU ; LIN XIAOYA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN113413461A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZENG WUJIANG</creatorcontrib><creatorcontrib>LIN DEQIU</creatorcontrib><creatorcontrib>CHEN SHUICHUN</creatorcontrib><creatorcontrib>CHEN HUASHENG</creatorcontrib><creatorcontrib>LIN ZHOU</creatorcontrib><creatorcontrib>LIN XIAOYA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZENG WUJIANG</au><au>LIN DEQIU</au><au>CHEN SHUICHUN</au><au>CHEN HUASHENG</au><au>LIN ZHOU</au><au>LIN XIAOYA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Anti-senile dementia medicine and preparation method thereof</title><date>2021-09-21</date><risdate>2021</risdate><abstract>The invention belongs to the technical field of medicines, and particularly relates to an anti-senile dementia medicine and a preparation method thereof. When the total mass of the anti-senile dementia medicine is 100%, and the anti-senile dementia medicine comprises the following components: 30%-60% of fucose; 10%-40% of astragalus polysaccharide; 10%-40% of lentinan; and 20%-50% of snake venom nerve growth factors. The anti-senile dementia medicine provided by the invention has a better treatment effect on senile dementia through the synergistic effect of all the components, and can promote the release of acetylcholine in limbs and trunks, cause the balance of acetylcholine and dopamine in the brain, treat and relieve the symptoms of senile dementia and recover intelligence and memory to a certain extent.
本申请属于医药技术领域，尤其涉及一种抗老年痴呆药物及其制备方法。其中，以所述抗老年痴呆药物的总质量为100％计，包括以下组分：岩藻糖30％～60％；黄芪多糖10％～40％；香菇多糖10％～40％；蛇毒神经生长因子20％～50％。本申请提供的抗老年痴呆药物，通过各组分的协同配合作用，对老年性痴呆有较好的治疗作用，能促进四肢躯干的乙酰胆碱释放，导致脑内的乙酰胆碱及多巴胺平衡，治疗和缓解老年性痴呆的症状，以及在一</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN113413461A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Anti-senile dementia medicine and preparation method thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T19%3A38%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZENG%20WUJIANG&rft.date=2021-09-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN113413461A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |